Since acetylcholine plays many roles in central and peripheral cholinergic neurotransmission, in neuromuscular communication and also in interacting with other neurotransmitter pathways, cholinesterase inhibitors are a mainstay of AD therapy (Nordberg et al. 2009). The gene discussed is BCHE; the disease is Alzheimer disease.